General Information of the Compound
Compound ID
CP0522749
Compound Name
5,6,7,8-tetrahydroanthracene-1,4-dione
    Show/Hide
Synonyms
5,6,7,8-tetrahydroanthracene-1,4-dione
CHEMBL508233
SCHEMBL11038167
    Show/Hide
Structure
Formula
C14H12O2
Molecular Weight
212.248
Canonical SMILES
O=C1C=CC(=O)c2cc3CCCCc3cc12
    Show/Hide
InChI
InChI=1S/C14H12O2/c15-13-5-6-14(16)12-8-10-4-2-1-3-9(10)7-11(12)13/h5-8H,1-4H2
    Show/Hide
InChIKey
DWXLNXHEUIUNRF-UHFFFAOYSA-N
Physicochemical Property
logP
2.5006
Rotatable Bonds
0
Heavy Atom Count
16
Polar Areas
34.14
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44582382
ChEMBL ID
CHEMBL508233
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06969, Dual specificity protein phosphatase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 21800 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000072 A2780 Homo sapiens (Human)  1
1
IC50 = 750 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 5,6,7,8-tetrahydroanthracene-1,4-dione )
Drug Name 5,6,7,8-tetrahydroanthracene-1,4-dione
Target(s)
M-phase inducer phosphatase 2 (MPIP2)
Inhibitor